Vigabatrin is an anticonvulsant. It is known to work by stopping the breakdown of a natural calming substance (GABA) in the brain
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
They will commercialize molnupiravir in the international markets
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
The stability is led by healthy demand in the domestic and emerging markets
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Subscribe To Our Newsletter & Stay Updated
